AU2659588A - 3-hydroxy-2-(4-methoxyphenyl)-5-(2-methylaminoethyl)-2, 3-dihydro-5h-1, 5-benzothiazepin-4-one derivatives, their preparation and their application in therapy - Google Patents

3-hydroxy-2-(4-methoxyphenyl)-5-(2-methylaminoethyl)-2, 3-dihydro-5h-1, 5-benzothiazepin-4-one derivatives, their preparation and their application in therapy

Info

Publication number
AU2659588A
AU2659588A AU26595/88A AU2659588A AU2659588A AU 2659588 A AU2659588 A AU 2659588A AU 26595/88 A AU26595/88 A AU 26595/88A AU 2659588 A AU2659588 A AU 2659588A AU 2659588 A AU2659588 A AU 2659588A
Authority
AU
Australia
Prior art keywords
benzothiazepin
methylaminoethyl
methoxyphenyl
dihydro
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU26595/88A
Other versions
AU609681B2 (en
Inventor
Colombe Denys
Christian Hoornaert
Alistair Lochead
Jean-Claude Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of AU2659588A publication Critical patent/AU2659588A/en
Application granted granted Critical
Publication of AU609681B2 publication Critical patent/AU609681B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU26595/88A 1987-12-08 1988-12-07 3-hydroxy-2-(4-methoxyphenyl)-5-(2-methylaminoethyl)-2, 3-dihydro-5h-1, 5-benzothiazepin-4-one derivatives, their preparation and their application in therapy Ceased AU609681B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8717044A FR2624117B1 (en) 1987-12-08 1987-12-08 HYDROXY-3 (METHOXY-4 PHENYL) -2 (METHYLAMINO-2 ETHYL) -5 DIHYDRO-2,3 5H-BENZOTHIAZEPINE-1,5 ONE-4 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR8717044 1987-12-08

Publications (2)

Publication Number Publication Date
AU2659588A true AU2659588A (en) 1989-06-08
AU609681B2 AU609681B2 (en) 1991-05-02

Family

ID=9357609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26595/88A Ceased AU609681B2 (en) 1987-12-08 1988-12-07 3-hydroxy-2-(4-methoxyphenyl)-5-(2-methylaminoethyl)-2, 3-dihydro-5h-1, 5-benzothiazepin-4-one derivatives, their preparation and their application in therapy

Country Status (13)

Country Link
EP (2) EP0320361A1 (en)
JP (2) JPH01190632A (en)
KR (1) KR890009901A (en)
AU (1) AU609681B2 (en)
DK (1) DK681088A (en)
FI (1) FI885670A (en)
FR (1) FR2624117B1 (en)
HU (1) HU201538B (en)
IL (1) IL88608A0 (en)
NO (1) NO167802C (en)
NZ (1) NZ227235A (en)
PT (1) PT89182A (en)
ZA (1) ZA889169B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616003B2 (en) * 1988-04-19 1991-10-17 Synthelabo Benzothiazepin-4-one derivatives, their preparation and their application in therapy

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963545A (en) * 1988-05-24 1990-10-16 Marion Laboratories, Inc. Benzothiazepine anti-seizure method
US5134139A (en) * 1989-08-31 1992-07-28 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and preparation thereof
FR2653122B1 (en) * 1989-10-17 1994-04-15 Synthelabo DERIVATIVES OF 5- [2 - [[2-AMINO-2-OXOETHYL] METHYLAMINO] ETHYL] -2,3-DIHYDRO-3-HYDROXY-2- (4-METHOXYPHENYL) -1.5 (5H) -BENZOTHIAZEPINE-4 -ONE, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS.
CA2030160A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Benzothiazepine metastasis treatment
CA2030159A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Anti-cancer drug potentiators
FR2670785B1 (en) * 1990-12-20 1993-07-09 Synthelabo (METHOXY-4 PHENYL) -2 (METHYLAMINO-2 ETHYL) -5 DIHYDRO-2,3 5H-BENZOTHIAZEPINE-1,5 ONE-4 DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
DE69411387T2 (en) * 1994-09-16 1999-02-25 Orion Corp Fermion Process for the preparation of pharmaceutically active benzothiazepine derivatives.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (en) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "BENZAZEPINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS"
US4585768A (en) * 1984-04-10 1986-04-29 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and processes for preparing the same
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
EP0256888B1 (en) * 1986-08-20 1991-07-03 McNeilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
FR2630109B1 (en) * 1988-04-19 1991-11-29 Synthelabo DERIVATIVES OF ((N- (2-AMINO-2 OXO-2 ETHYL) METHYLAMINO) -2 ETHYL) -5 HYDROXY-3 (METHOXY-4 PHENYL) -2 DIHYDRO-2,3 5H-BENZOTHIAZEPINE-1,5 ONE-4, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU616003B2 (en) * 1988-04-19 1991-10-17 Synthelabo Benzothiazepin-4-one derivatives, their preparation and their application in therapy

Also Published As

Publication number Publication date
DK681088A (en) 1989-06-09
FI885670A (en) 1989-06-09
FR2624117A1 (en) 1989-06-09
FI885670A0 (en) 1988-12-07
NO885435D0 (en) 1988-12-07
HU201538B (en) 1990-11-28
HUT50797A (en) 1990-03-28
DK681088D0 (en) 1988-12-07
NO167802B (en) 1991-09-02
JPH01190632A (en) 1989-07-31
NZ227235A (en) 1990-06-26
KR890009901A (en) 1989-08-04
EP0320362A1 (en) 1989-06-14
NO885435L (en) 1989-06-09
PT89182A (en) 1989-12-29
EP0320361A1 (en) 1989-06-14
AU609681B2 (en) 1991-05-02
IL88608A0 (en) 1989-07-31
ZA889169B (en) 1990-05-30
FR2624117B1 (en) 1991-02-22
NO167802C (en) 1991-12-11
JPH01190674A (en) 1989-07-31

Similar Documents

Publication Publication Date Title
AU649605B2 (en) Retinal, derivatives and their therapeutic use
IL83198A0 (en) Benzenesulphonamidoindanyl derivatives,their preparation and medicaments containing them
GR3002636T3 (en) Pyrimidine derivatives, their preparation and medicaments containing these derivatives
AU6675490A (en) Heterocyclic derivatives, their preparation and medicinal products containing them
AU2166292A (en) Dried blood cells and method of preparation
AU1907788A (en) N-aminobutyl-n-phenylarylamide derivatives, their preparation and their application in therapy
AU629602B2 (en) Derivatives of benzocycloalkenyldihydroxyalkanoic, processes of preparation and medications containing them
AU3481989A (en) Substituted 3-(n-heterocyclic)-2,6-diaminopyridines and -n-oxides, their preparation and use as medicaments
AU2659588A (en) 3-hydroxy-2-(4-methoxyphenyl)-5-(2-methylaminoethyl)-2, 3-dihydro-5h-1, 5-benzothiazepin-4-one derivatives, their preparation and their application in therapy
AU618865B2 (en) Adenosin derivatives, their preparation and use
ZA862708B (en) Nitrofuran derivatives,the preparation thereof and their application in therapy
AU575711B2 (en) 2-(4,5-dihydro-1h-imidazol-2-yl)-2,3-dihydroindole derivatives the preparation therof and their application in therapy
EP0256400A3 (en) Pyrimidine derivatives, their preparation and medicaments containing these derivatives
ZA879235B (en) Peridone derivatives,and their preparation and use
AU7143887A (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
DE3760415D1 (en) Benzaldehyde derivatives, their preparation and application
AU1507992A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
ZA894422B (en) Pyrrole derivatives,their preparation and their use as pharmaceutical active compounds
AU8282187A (en) 5-hydroxyethyl derivatives of oxazolidinone-2, their preparation and their therapeutic uses
AU578739B2 (en) Vinyltetrazolylphenyl derivatives, their preparation and their use
AU3315289A (en) Benzothiazepin-4-one derivatives, their preparation and their application in therapy
AU4266089A (en) 3-aryloxymethyl-cephalosporin derivatives, their preparation and their medical use
AU8129987A (en) Pyrrolo-benzimidazoles, their preparation and use
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
AU8268887A (en) Aminoethylisoxazolidines, their preparation and use